Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
Thomas Hueso(Institut Gustave Roussy), Karine Lacombe(Inserm)
Cited by 299
Related Papers
Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
|Gut|2015|273
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
|Nature Cancer|2020|119
Linkage and retention in <scp>HCV</scp> care for <scp>HIV</scp>‐infected populations: early data from the <scp>DAA</scp> era
|Journal of the International AIDS Society|2018|53